Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
2501	QC QCM Cayman Houston, Texas	$0	-$533K	0	–	Closed
2502	RCA Rex Capital Advisors Providence, Rhode Island	$0	-$206K	0	–	Closed
2503	RCP Rothschild Capital Partners New York	$0	-$260K	0	–	Closed
2504	SC Scholtz & Company Stamford, Connecticut	$0	-$895K	0	–	Closed
2505	SH SeaTown Holdings Singapore	$0	-$10.2M	0	–	Closed
2506	SCM Segantii Capital Management Hong Kong	$0	-$9.46M	0	–	Closed
2507	SAM Sentinel Asset Management Montpelier, Vermont	$0	-$21.1M	0	–	Closed
2508	SM SG3 Management Dorado, Puerto Rico	$0	-$1.1M	0	–	Closed
2509	SCM Sio Capital Management New York	$0	-$10.1M	0	–	Closed
2510	SAMC Spectrum Asset Management (California) Newport Beach, California	$0	-$967K	0	–	Closed
2511	SCM Suffolk Capital Management New York	$0	-$15M	0	–	Closed
2512	SD Sumway Development Shanghai, China	$0	-$7.91M	0	–	Closed
2513	SPM Symmetry Peak Management Radnor, Pennsylvania	$0	-$1.06M	0	–	Closed
2514	TAS TIFF Advisory Services Radnor, Pennsylvania	$0	-$505K	0	–	Closed
2515	VMI VHCP Management II New York	$0	-$1.55M	0	–	Closed
2516	WCM Wildcat Capital Management New York	$0	-$1.05M	0	–	Closed
2517	Wolverine Asset Management Chicago, Illinois	$0	$0	0	–	Closed
2518	WVP Worth Venture Partners Fort Lee, New Jersey	$0	-$1.32M	0	–	Closed
2519	ZDA Zweig-DiMenna Associates New York	$0	-$592K	0	–	Closed